- CDP Homepage
- What is CDP?
- What are the Benefits?
- What is the Process?
- CDP Team
- News & Events
- News - Deal struck for Leukaemia and Lymphoma drug trials
- News - CR-UK and GSK join forces to trial new drug
- News - CR-UK and Astex Therapeutics
- News - Promising anti-cancer compound deal with AstraZeneca
- News - Immatics trial for brain cancer vaccine
- News - AS1404 drug trials
- PR - CDP launched
- Events
- Contact Us
News and Events
Latest News
- 16 February 2010
Cancer Research UK and Immatics Biotechnologies to trial vaccine for brain cancer - 4 January 2010
Deal struck for new investigational anti-cancer drug to target leukaemia and lymphoma - 20 May 2009
Cancer Research UK and GlaxoSmithKline join forces to trial new anti-cancer drug - 29 September 2008
Cancer Research UK and Astex Therapeutics join forces to develop new anti-cancer treatment - 19 May 2008
Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound - 27 September 2006
Trials of AS1404 for lung cancer show encouraging results
For all media enquiries on CDP, please contact the Press Office on tel: 020 7061 8300 or out of office hours, the Duty Press Officer on 07050 264 059. For non-urgent enquiries, you can email pressoffice@cancer.org.uk.
For all other enquiries please email enquiries@clinicalpartnerships.com
